The neuroprotective effects of PPARγ have also been widely documented in vitro in various experimental paradigms of neurodegeneration, broadening its potential therapeutic perspectives in MS [45,75,76,77,78,79]. The gene discussed is PPARG; the disease is myeloid sarcoma.